Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease
Tools
Herd, Clare P, Tomlinson, Claire L, Deane, Katherine, Brady, Marian C, Smith, Christina H, Sackley, Catherine M and Clarke, Carl E (2012) Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane database of systematic reviews (Online), 8. CD002812.
![]()
|
PDF (Herd-2012-Speech and language)
- Published Version
Download (411kB) | Preview |
Abstract
Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | randomized controlled trials as topic,watchful waiting,parkinson disease,speech intelligibility,humans,dysarthria,speech therapy,language therapy |
Faculty \ School: | Faculty of Medicine and Health Sciences > School of Rehabilitation Sciences |
Depositing User: | Pure Connector |
Date Deposited: | 16 Oct 2013 00:43 |
Last Modified: | 16 Feb 2021 00:43 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/43707 |
DOI: | 10.1002/14651858.CD002812.pub2 |
Actions (login required)
![]() |
View Item |